Salmon Calcitonin
Calcitonin for bone loss and hypercalcemia. Potent osteoclast inhibitor reducing bone resorption, serum calcium, and Paget’s disease activity with rapid onset of action.
Salmon Calcitonin is a polypeptide hormone derived from salmon ultimobranchial glands, consisting of 32 amino acids with a disulfide bridge between Cys1 and Cys7. It is approximately 30-50 times more potent than human calcitonin in inhibiting osteoclast-mediated bone resorption. It is indicated for the treatment of osteoporosis, Paget’s disease of bone, hypercalcemia, and bone pain, and is widely used in both injectable and nasal spray formulations.
| Parameter | Specification |
| CAS | 47931-85-1 |
| Molecular Formula | C₁₄₅H₂₄₀N₄₄O₄₈S₂ |
| Molecular Weight | 3431.85 g/mol |
| Category | Bone Health |
| Purity | ≥99% |
| Status | GMP-compliant, FDA-ready |
| Applications | Osteoporosis, hypercalcemia, Paget’s disease, bone pain |
| CAS | 47931-85-1 |
|---|---|
| Applications |
Related products
-
Retatrutide
CAS: 2381089-83-2Applications: Refractory diabetes, Severe obesity, Triple agonist, weight management -
Ganirelix
CAS: 123246-29-7 -
Abarelix
CAS: 183552-38-7Applications: Advanced Prostate Cancer, Hormone-dependent Tumors, Testosterone Suppression -
Apraglutide
CAS: 1295353-98-8Applications: GLP-2, Intestinal Repair, Mucosal Growth, Short Bowel Syndrome